112 related articles for article (PubMed ID: 33105923)
1. [Exploring the health education model for chronic hepatitis C micro-elimination in Guizhou Province from a global perspectives].
Luo XH; Liang YD; Peng H; Ning JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):816-819. PubMed ID: 33105923
[TBL] [Abstract][Full Text] [Related]
2. Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project.
Kobayashi H; Joshita S; Akahane Y; Matsuzaki K; Yamada H; Aomura D; Joshita N; Midorikawa H; Suyama K; Ota M; Wakabayashi SI; Yamashita Y; Sugiura A; Yamazaki T; Misawa H; Umemura T
PLoS One; 2021; 16(8):e0256711. PubMed ID: 34437651
[TBL] [Abstract][Full Text] [Related]
3. Global elimination of hepatitis C virus by 2030: why not?
Dore GJ; Martinello M; Alavi M; Grebely J
Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
[No Abstract] [Full Text] [Related]
4. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
5. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
6. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
[TBL] [Abstract][Full Text] [Related]
7. Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
van Dijk M; Kracht PAM; Arends JE; Blokzijl H; Burger DM; van Erpecum KJ; van Hoek B; de Knegt RJ; Posthouwer D; Ramsoekh D; Rijnders BJA; Schinkel J; Willemse SB; van der Valk M; Drenth JPH; Behalf Of The HepNed Study Group O
Neth J Med; 2019 May; 77(4):131-138. PubMed ID: 31502544
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
9. Countdown to 2030: eliminating hepatitis B disease, China.
Liu J; Liang W; Jing W; Liu M
Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis C.
Czepiel J; Biesiada G; Mach T
Pol Arch Med Wewn; 2008 Dec; 118(12):734-40. PubMed ID: 19202952
[TBL] [Abstract][Full Text] [Related]
11. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
12. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
[TBL] [Abstract][Full Text] [Related]
13. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of the National Action Plan for Eliminating Hepatitis C as a Public Health Threat (2021-2030).
Li J; Pang L; Liu Z
China CDC Wkly; 2022 Jul; 4(29):627-630. PubMed ID: 35919827
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Smith BD; Morgan RL; Beckett GA; Falck-Ytter Y; Holtzman D; Teo CG; Jewett A; Baack B; Rein DB; Patel N; Alter M; Yartel A; Ward JW;
MMWR Recomm Rep; 2012 Aug; 61(RR-4):1-32. PubMed ID: 22895429
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
[TBL] [Abstract][Full Text] [Related]
17. HBV and HCV test uptake and correlates among men who have sex with men in China: a nationwide cross-sectional online survey.
Fitzpatrick T; Pan SW; Tang W; Guo W; Tucker JD
Sex Transm Infect; 2018 Nov; 94(7):502-507. PubMed ID: 29779005
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis C: achievement, challenge and strategy to eliminate as a public health threat].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):161-168. PubMed ID: 29804387
[TBL] [Abstract][Full Text] [Related]
19. How would China achieve WHO's target of eliminating HCV by 2030?
Li M; Zhuang H; Wei L
Expert Rev Anti Infect Ther; 2019 Oct; 17(10):763-773. PubMed ID: 31578079
[No Abstract] [Full Text] [Related]
20. Micro-elimination of hepatitis C virus infection in β-Thalassaemia major patients: Positively moving towards the World Health Organisation 2030 eradication goal.
Giannini EG; Aghemo A
Dig Liver Dis; 2019 Apr; 51(4):568-569. PubMed ID: 30691776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
